Larimar Therapeutics (LRMR) Times Interest Earned: 2014-2020
Historic Times Interest Earned for Larimar Therapeutics (LRMR) over the last 6 years, with Mar 2020 value amounting to -$11.84.
- Larimar Therapeutics' Times Interest Earned rose 55.42% to -$11.84 in Q1 2020 from the same period last year, while for Mar 2020 it was -$22.94, marking a year-over-year increase of 24.20%. This contributed to the annual value of -$25.85 for FY2019, which is 19.72% up from last year.
- Latest data reveals that Larimar Therapeutics reported Times Interest Earned of -$11.84 as of Q1 2020, which was up 41.15% from -$20.11 recorded in Q4 2019.
- In the past 5 years, Larimar Therapeutics' Times Interest Earned ranged from a high of -$11.84 in Q1 2020 and a low of -$1,670 during Q4 2017.
- Over the past 3 years, Larimar Therapeutics' median Times Interest Earned value was -$29.44 (recorded in 2018), while the average stood at -$27.04.
- In the last 5 years, Larimar Therapeutics' Times Interest Earned plummeted by 1,446.21% in 2017 and then skyrocketed by 98.24% in 2018.
- Over the past 5 years, Larimar Therapeutics' Times Interest Earned (Quarterly) stood at -$107.99 in 2016, then tumbled by 1,446.21% to -$1,670 in 2017, then soared by 98.24% to -$29.44 in 2018, then surged by 31.68% to -$20.11 in 2019, then soared by 55.42% to -$11.84 in 2020.
- Its last three reported values are -$11.84 in Q1 2020, -$20.11 for Q4 2019, and -$30.30 during Q3 2019.